Lilly(Eli) & Co XNYS: LLY

Expensive Performer

839.96 105.06 (14.30%)

10.8M XNYS Volume

XNYS 17 Apr, 2025 5:30 PM (EDT)

Positive Trial

Eli Lilly rises as its new diabetes drug, Orforglipron, shows positive phase-3 trial results See details

Detailed Stock Analysis for Lilly(Eli) & Co with Real-time Stock Report